The prognosis of solid tumors is predominantly influenced by the anatomic e
xtent before and after initial treatment. It is defined by the TNM/pTNM sys
tem and the residual tumor (R) classification as internationally agreed on
and published by the International Union Against Cancer (UICC). However, th
ere are several independent factors effective in prognosis in addition to T
NM and R. Their identification is the first objective in prognostic factor
research. Correctly applied multivariate methods appropriate for the specif
ic situation play a key role. Cooperation between clinical oncologists and
experienced medical statisticians is indispensable. Putative new prognostic
factors have to be carefully evaluated before they can be accepted for gen
eral use in clinical oncology. In the future, we have to focus on the devel
opment of prognostic systems. Such systems integrate multiple independent p
rognostic factors with present staging (TNM, R) to improve the assessment o
f prognosis. (C) 1999 Elsevier Science Inc.